Dermata Therapeutics Inc (DRMA) — Financial Flexibility Index
Dermata Therapeutics Inc (DRMA) has a Financial Flexibility Index of -0.81x as of December 2025. Free cash flow of $-1.33 Million (operating CF $-1.33 Million minus capex $3.00) represents -1% of total liabilities ($1.64 Million). Also explore how fast is Dermata Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dermata Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Dermata Therapeutics Inc across 7 annual periods. See DRMA net asset quality score to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Dermata Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Dermata Therapeutics Inc. For the full company profile including market capitalisation, see Dermata Therapeutics Inc (DRMA) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.73x | $-7.76 Billion | $-7.76 Billion | $1.64 Billion | ▲ +16.4% |
| 2024 | -5.66x | $-11.16 Million | $-11.16 Million | $1.97 Million | ▼ -43.3% |
| 2023 | -3.95x | $-6.41 Million | $-6.41 Million | $1.62 Million | ▲ +58.8% |
| 2022 | -9.57x | $-8.83 Million | $-8.83 Million | $922.63K | ▼ -155.1% |
| 2021 | -3.75x | $-5.69 Million | $-5.69 Million | $1.52 Million | ▼ -252.5% |
| 2020 | -1.06x | $-4.03 Million | $-4.03 Million | $3.78 Million | ▲ +38.2% |
| 2019 | -1.72x | $-3.92 Million | $-3.92 Million | $2.28 Million | — |